Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 5.03
-0.10 (-1.95%)
Feb 5, 2026, 5:29 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 244.13 million as of February 5, 2026. Its market cap has increased by 205.12% in one year.
Market Cap
244.13M
Enterprise Value
209.21M
Revenue
13.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.03
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 244.13M, an increase of 99.05%. That is a compound annual growth rate of 15.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 248.99M | -1.72% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | 122.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascelia Pharma AB | 338.11M |
| Mendus AB | 317.80M |
| Intervacc AB | 297.19M |
| Lipum AB | 294.85M |
| Bio-Works Technologies AB | 283.36M |
| Xintela AB | 242.88M |
| Magle Chemoswed Holding AB | 233.34M |
| AlzeCure Pharma AB | 228.68M |